ME1 Biomarkers for interstitial lung disease

Meet the expert
Aims: To critically review the most recent findings in interstitial lung disease (ILD) biomarker research including discovery tools; and to understand how biomarkers could be used to clinically manage specific forms of ILD such as idiopathic pulmonary fibrosis (IPF) or connective tissue disease (CTD)-ILD.

How to access educational materials from mobile devices
Biomarkers for interstitial lung disease
Martin Kolb (Hamilton, Canada)
PDF journal article, handout or slidesPDF journal article, handout or slidesWebcastSlide presentation
PDF journal article, handout or slidesPDF journal article, handout or slidesWebcastSlide presentation